Skip to main content
Premium Trial:

Request an Annual Quote

San Diego State Teams Up with Biotech to Teach Biology and Business

NEW YORK, Feb. 3 (GenomeWeb News) - San Diego State University, Invitrogen, Pfizer, and CardioDynamics are teaming up to establish a joint PhD-MBA program in the life sciences, Invitrogen said today.

 

The aim is to educate studies in scientific research as well as the business of biotechnology. The program is poised to expand from a two-student pilot program that SDSU launched last September. SDSU offers the PhD part of the program in conjunction with the University of California, San Diego.

 

Invitrogen, Pfizer, and CardioDynamics are funding the startup phase of the program. In addition, Carlsbad, Calif.-based Invitrogen offers students lectures, case studies, and internships.

 

At the moment, SDSU is trying to raise additional funding for the program.

 

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.